Advertisement
Journal Home
Search for

Volume 38, Issue 1, Pages 26-30 (February 2010)


View previous. 9 of 25 View next.

Virucidal efficacy of disinfectant actives against feline calicivirus, a surrogate for norovirus, in a short contact time

Kelly Whitehead, BS, Karen A. McCue, BS, MSCorresponding Author Informationemail address

published online 21 July 2009.

Background

Among other measures, handwashing and targeted disinfection are important in preventing and controlling norovirus outbreaks. Presently, there are a limited number of disinfectants effective against norovirus. There is a need to develop alternatives to bleach that are effective against norovirus, and, in particular, fast-acting disinfectants are desired. The aim of this study was to determine the disinfectant actives and formulation factors necessary to achieve efficacy against norovirus in a short contact time.

Methods

Feline calicivirus (FCV) was used as a surrogate for norovirus. In a carrier test method, common disinfectant actives including alcohol, acid, quaternary compound, and phenol both alone and as formulated disinfectants were contacted with dried FCV virus for 1minute. The virus treatment was neutralized and assayed in Crandell-Reese kidney cells for cytopathic effect. Log10 virus inactivation was calculated comparing treatment results to virus control titer.

Results

Bleach and acid-based disinfectants inactivate FCV in 1minute. Inactivation of FCV by alcohol and quaternary actives depends on how these actives are formulated as disinfectants. Actives and extreme pH are determined predictive of efficacy. Ethanol and quaternary compounds formulated at appropriate concentration and alkaline pH inactivates FCV in 1-minute contact.

Conclusion

Acid cleaners, ethanol, and quaternary compounds formulated at appropriate concentration and pH can be fast-acting antimicrobial choices and alternatives to bleach for the consumer and health care providers to use to inactivate FCV, a surrogate for norovirus, and protect against this important pathogen.

Reckitt Benckiser Inc., Center of Innovation, Microbiology and Virology Department, Montvale, NJ

Corresponding Author InformationAddress correspondence to Karen A. McCue, BS, MS, Reckitt Benckiser Inc., Center of Innovation, One Philips Parkway, Montvale, NJ 07645.

 Supported by Reckitt Benckiser Inc., Research and Development.

 Conflicts of interest: Both authors are employees of Reckitt Benckiser.

PII: S0196-6553(09)00597-5

doi:10.1016/j.ajic.2009.03.015


View previous. 9 of 25 View next.